ODTX · Insider Trading
Odyssey Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by ODTX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | TPG GP A, LLC | — | MIXED | +11,070,438 | +$74.87M |
| 2026-05-12 | Dimension Capital II, L.P. | Director | MIXED | +2,820,654 | +$20.00M |
| 2026-05-11 | Ourania Tatsis | Director | A | +27,393 deriv. | — |
| 2026-05-11 | Valerie Odegard | Director | A | +27,393 deriv. | — |
| 2026-05-11 | Collin M Todd | See Remarks | A | +93,904 deriv. | — |
| 2026-05-11 | Jason Haas | Chief Financial Officer | Buy | +1,000 | +$20.00K |
| 2026-05-11 | Natalie Dales | See Remarks | A | +79,773 deriv. | — |
| 2026-05-11 | Ian F Smith | Director | A | +27,393 deriv. | — |
| 2026-05-11 | Gary D Glick | See Remarks | C | +27,386 | — |
| 2026-05-11 | Timothy P Walbert | Director | A | +27,393 deriv. | — |
| 2026-05-11 | Nan (LN) Li | Director | MIXED | +2,820,654 | +$20.00M |
| 2026-05-11 | Shelley Chu | Director | Buy | +11,111 | +$200.00K |
| 2026-05-11 | Jeffrey M Leiden | Director | MIXED | +36,644 | +$99.69K |
| 2026-05-11 | Anthony W. Opipari | See Remarks | MIXED | +7,502 | −$72 |
| 2026-05-11 | Simeon George | 10%+ Owner | MIXED | +7,589,766 | +$19.94M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Dimension Capital II, L.P. | Director | 3,333,516 | $60.40M |
| TPG GP A, LLC | — | 2,301,257 | $41.70M |
| Nan (LN) Li | Director | 2,222,405 | $40.27M |
| Simeon George | 10%+ Owner | 734,868 | $13.32M |
| Gary D Glick | See Remarks | 415,973 | $7.54M |
| Jeffrey M Leiden | Director | 298,896 | $5.42M |
| Jason Haas | Chief Financial Officer | 62,908 | $1.14M |
| Shelley Chu | Director | 11,111 | $201.33K |
| Anthony W. Opipari | See Remarks | 6,965 | $126.21K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ODTX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.